Sankyo Sues Nissin Over Mevalotin Patent
Japanese drug maker Sankyo has filed a lawsuit against domestic rival Nissin Pharmaceutical over its flagship hyperlipidaemia drug Mevalotin (pravastatin), which Sankyo developed after discovering the world's first cholesterol inhibitor....To view the full article, register now.
Already a subscriber? Click here to view full article